Compounds > midazolam

midazolam and thalidomide

midazolam has been researched along with thalidomide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Guengerich, FP; Murayama, N; Okada, Y; Shimizu, M; Yamazaki, H; Yanagida, C1
Guengerich, FP; Murayama, N; Nakamura, M; Shibata, N; Suemizu, H; Utoh, M; Yamazaki, H1
Chaplain, MAJ; Hill, L; Kapelyukh, Y; Wolf, R1

Reviews

1 review(s) available for midazolam and thalidomide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for midazolam and thalidomide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.
    Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Kinetics; Liver; Midazolam; Thalidomide

2009
In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice.
    Chemical research in toxicology, 2013, Mar-18, Volume: 26, Issue:3

    Topics: Adjuvants, Anesthesia; Animals; Chimera; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Immunosuppressive Agents; Liver; Male; Mice; Midazolam; Teratogens; Thalidomide

2013
The usage of a three-compartment model to investigate the metabolic differences between hepatic reductase null and wild-type mice.
    Mathematical medicine and biology : a journal of the IMA, 2017, 03-01, Volume: 34, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Cytochrome P-450 Enzyme System; Disease Models, Animal; GABA Modulators; Gefitinib; Liver; Mice; Mice, Transgenic; Midazolam; Models, Biological; NADPH-Ferrihemoprotein Reductase; Protein Kinase Inhibitors; Quinazolines; Thalidomide

2017